Can-Fite BioPharma Future Growth
Future criteria checks 2/6
Can-Fite BioPharma is forecast to grow earnings and revenue by 38.2% and 67.5% per annum respectively while EPS is expected to grow by 171.4% per annum.
Key information
38.2%
Earnings growth rate
171.4%
EPS growth rate
| Biotechs earnings growth | 47.9% |
| Revenue growth rate | 67.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 10 Oct 2024 |
Recent future growth updates
Recent updates
It's Unlikely That Can-Fite BioPharma Ltd.'s (TLV:CANF) CEO Will See A Huge Pay Rise This Year
Jun 19
Is Can-Fite BioPharma (TLV:CANF) In A Good Position To Invest In Growth?
Jun 30We're Not Very Worried About Can-Fite BioPharma's (TLV:CANF) Cash Burn Rate
Mar 08Is Can-Fite BioPharma (TLV:CANF) In A Good Position To Deliver On Growth Plans?
Nov 21Can-Fite BioPharma (TLV:CANF) Will Have To Spend Its Cash Wisely
May 16We're A Little Worried About Can-Fite BioPharma's (TLV:CANF) Cash Burn Rate
Jan 31
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 0 | -8 | 20 | -9 | 2 |
| 12/31/2025 | 11 | 1 | 21 | 21 | 3 |
| 12/31/2024 | 1 | -8 | -9 | -9 | 3 |
| 6/30/2024 | 1 | -7 | -7 | -7 | N/A |
| 3/31/2024 | 1 | -7 | N/A | N/A | N/A |
| 12/31/2023 | 1 | -8 | -8 | -8 | N/A |
| 9/30/2023 | 1 | -9 | N/A | N/A | N/A |
| 6/30/2023 | 1 | -10 | -10 | -10 | N/A |
| 3/31/2023 | 1 | -10 | N/A | N/A | N/A |
| 12/31/2022 | 1 | -10 | -11 | -11 | N/A |
| 9/30/2022 | 1 | -14 | N/A | N/A | N/A |
| 6/30/2022 | 1 | -15 | -12 | -12 | N/A |
| 3/31/2022 | 1 | -16 | N/A | N/A | N/A |
| 12/31/2021 | 1 | -15 | -10 | -10 | N/A |
| 9/30/2021 | 1 | -12 | N/A | N/A | N/A |
| 6/30/2021 | 1 | -11 | -7 | -7 | N/A |
| 3/31/2021 | 1 | -12 | N/A | N/A | N/A |
| 12/31/2020 | 1 | -15 | -12 | -12 | N/A |
| 9/30/2020 | 1 | -13 | N/A | N/A | N/A |
| 6/30/2020 | 2 | -17 | -14 | -14 | N/A |
| 3/31/2020 | 2 | -13 | N/A | N/A | N/A |
| 12/31/2019 | 2 | -13 | -11 | -11 | N/A |
| 9/30/2019 | 2 | -11 | N/A | N/A | N/A |
| 6/30/2019 | 4 | -8 | -8 | -8 | N/A |
| 3/31/2019 | 3 | -7 | N/A | N/A | N/A |
| 12/31/2018 | 4 | -7 | -4 | -4 | N/A |
| 9/30/2018 | 4 | -5 | N/A | N/A | N/A |
| 6/30/2018 | 2 | -6 | -5 | -5 | N/A |
| 3/31/2018 | 1 | -5 | N/A | N/A | N/A |
| 12/31/2017 | 1 | -6 | N/A | -9 | N/A |
| 9/30/2017 | 1 | -6 | N/A | N/A | N/A |
| 6/30/2017 | 0 | -9 | N/A | -9 | N/A |
| 3/31/2017 | 0 | -7 | N/A | N/A | N/A |
| 12/31/2016 | 0 | -8 | N/A | -9 | N/A |
| 9/30/2016 | 0 | -5 | N/A | N/A | N/A |
| 6/30/2016 | 0 | -6 | N/A | -8 | N/A |
| 3/31/2016 | 0 | -6 | N/A | N/A | N/A |
| 12/31/2015 | 0 | -6 | N/A | -5 | N/A |
| 9/30/2015 | 0 | -7 | N/A | N/A | N/A |
| 6/30/2015 | 0 | -5 | N/A | -5 | N/A |
| 3/31/2015 | N/A | -5 | N/A | N/A | N/A |
| 12/31/2014 | N/A | -6 | N/A | -7 | N/A |
| 9/30/2014 | N/A | -7 | N/A | N/A | N/A |
| 6/30/2014 | N/A | -8 | N/A | -9 | N/A |
| 3/31/2014 | N/A | -8 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CANF is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CANF is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CANF is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CANF's revenue (67.5% per year) is forecast to grow faster than the IL market (2.6% per year).
High Growth Revenue: CANF's revenue (67.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CANF's Return on Equity is forecast to be high in 3 years time